Shanmuga Hospital Ltd (SHANMUGA) — shareholding pattern, promoter holding, financials and share price
About Shanmuga Hospital Ltd (SHANMUGA)
Shanmuga Hospital Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as SHANMUGA and on the BSE under scrip code 544365. Its ISIN is INE0TD301017.
Incorporated in 2020, Shanmuga Hospital Limited is a Multispecialty Hospital situated in Salem, Tamil Nadu. [1]
Shanmuga Hospital Limited, based in Salem, Tamil Nadu, is a multi-specialty hospital specializing in a range of advanced healthcare services including oncology, cardiac care, and robotic surgeries.
The hospital has successfully integrated advanced technologies such as the Da Vinci Xi robotic system and LINAC machines to offer precise cancer treatments, enhancing its reputation as a leading oncology center in the region.
Listed peers in Hospital: Fortis Malar Hospitals Ltd, Maitreya Medicare Ltd, Sangani Hospitals Ltd, Aatmaj Healthcare Ltd, Soni Medicare Ltd, KK Shah Hospitals Ltd.
Valuation & Returns
10 Jul 2026At ₹48.5 a share on 10 Jul 2026, Shanmuga Hospital Ltd (SHANMUGA) was valued at a price-to-earnings ratio of 14.94x against an industry P/E of 61.73x and a price-to-book of 1.48x on a book value of ₹31.22 per share. Solomo computes return on equity of 9.91% and return on capital employed of 12.37% from filed results.
- P/E
- 14.94x
- Industry P/E
- 61.73x
- P/B
- 1.48x
- EPS (TTM)
- ₹4.03
- Book value / share
- ₹31.22
- ROE
- 9.91%
- ROCE
- 12.37%
- ROA
- 7.93%
- Debt / equity
- 0.16x
- Dividend yield
- 0%
- EBITDA margin
- 18.78%
- 52-week range
- ₹34 – ₹56.76
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Shanmuga Hospital Ltd (SHANMUGA) reported revenue of ₹47.44 crore, net profit of ₹4.21 crore and earnings per share of ₹3.09. That compares with revenue of ₹45.41 crore and net profit of ₹4.21 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹22.82 crore and net profit ₹2.2 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 38.94 | 37.11 | 40.63 | 45.41 | 47.44 |
| Net profit (₹ cr) | 6.72 | 4.76 | 5.25 | 4.21 | 4.21 |
| EPS (₹) | 840 | 595 | 5.36 | 3.09 | 3.09 |
| Measure | 3Y | 1Y |
|---|---|---|
| Sales growth | 4.96% | 11.18% |
| Profit growth | -14.45% | -19.81% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 72.06% of Shanmuga Hospital Ltd (SHANMUGA). Market capitalisation was ₹66 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2025.
Largest disclosed public shareholders in Mar 2026: ASHOK KUMAR MADRECHA 2.34%, BLACK FOX FINANCIAL PRIVATE LIMITED 1.25%, MAHAMAYEE SUDHIR 1.22%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 72.06% | - | - | - | 27.94% |
| Sep 2025 | 72.06% | - | - | - | 27.94% |
| Mar 2025 | 72.11% | - | 0.19% | - | 27.89% |